Back to Search
Start Over
T-15-02: Efficacy, safety and consumption of plasma-derived von Willebrand factor (VWF)/Factor VIII (FVIII) concentrate with 2.4:1 VWF:FVIII ratio for the treatment of von Willebrand Disease: a systematic review.
- Source :
- Hämostaseologie; 2023 Supplement, Vol. 43, pS63-S64, 2p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 07209355
- Volume :
- 43
- Database :
- Complementary Index
- Journal :
- Hämostaseologie
- Publication Type :
- Academic Journal
- Accession number :
- 162983793
- Full Text :
- https://doi.org/10.1055/s-0042-1760558